NASDAQ | VICL: 1.02  -0.01

Cancer Immunotherapies

Our licensee Merial has received approval by the U.S. Department of Agriculture for ONCEPT®, a therapeutic cancer vaccine that was designed to extend the survival time of dogs with oral melanoma.  ONCEPT® was the first approved therapeutic vaccine for the treatment of cancer in either animals or humans.


View more videos from Vical.
P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121
Designed by Mentus
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.